IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,444 | -38.5% | 149,900 | -32.1% | 0.01% | -40.0% |
Q2 2023 | $2,349 | +256.4% | 220,800 | +252.7% | 0.02% | +200.0% |
Q1 2023 | $659 | -100.0% | 62,600 | -53.8% | 0.01% | -54.5% |
Q2 2022 | $1,562,000 | -48.9% | 135,500 | -44.2% | 0.01% | -38.9% |
Q1 2022 | $3,054,000 | -37.0% | 242,800 | -41.4% | 0.02% | -28.0% |
Q4 2021 | $4,850,000 | -83.3% | 414,500 | -81.3% | 0.02% | -84.3% |
Q3 2021 | $28,998,000 | +949.9% | 2,220,400 | +934.7% | 0.16% | +835.3% |
Q2 2021 | $2,762,000 | +14.6% | 214,600 | -0.5% | 0.02% | +6.2% |
Q1 2021 | $2,410,000 | -69.0% | 215,600 | -68.4% | 0.02% | -69.8% |
Q4 2020 | $7,778,000 | +115.3% | 682,900 | +70.0% | 0.05% | +103.8% |
Q3 2020 | $3,612,000 | +67.3% | 401,600 | +92.0% | 0.03% | +52.9% |
Q2 2020 | $2,159,000 | +155.2% | 209,200 | +149.6% | 0.02% | +325.0% |
Q1 2020 | $846,000 | -65.9% | 83,800 | -55.0% | 0.00% | -78.9% |
Q4 2019 | $2,478,000 | +3.4% | 186,200 | -19.5% | 0.02% | -9.5% |
Q4 2018 | $2,397,000 | – | 231,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |